CC
TECH icon

Capital Counsel’s Bio-Techne TECH Stock Holding History

Capital Counsel’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.86M Hold
73,850
– – 0.16% 20
2025
Q4 		$4.34M Sell
73,850
-150
-0.2% -$9.11K 0.17% 21
2025
Q3 		$4.12M Buy
+74,000
New +$3.96M 0.16% 21

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Counsel's TECH Position: Q1 2026 in Review

Capital Counsel held its Bio-Techne (TECH) position steady in Q1 2026 at 73,850 shares worth $3.86M. The position accounts for 0.16% of the portfolio, ranked #20.

Capital Counsel first reported a position in TECH in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.34M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Capital Counsel held 73,850 shares of Bio-Techne worth $3.86M as of Q1 2026.
  • Capital Counsel left its Bio-Techne share count unchanged in Q1 2026.
  • Bio-Techne made up 0.16% of Capital Counsel's portfolio in Q1 2026, its #20 holding.
  • Capital Counsel first reported a position in Bio-Techne in Q3 2025 and has held it in 3 quarters since.
  • Capital Counsel's Bio-Techne position peaked at $4.34M in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Capital Counsel's 13F filing for Q1 2026, filed 15 May 2026.